We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Evaluation shows high discrepancies in adverse event reporting between trial registries and publications in COVID-19 therapeutics, suggesting important gaps in data accuracy.
Discrepant reporting of AEs and essential trial data was high in trials on COVID-19 therapeutics.
No takes yet. Share an insight, caveat, or question.
Strikić et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: